Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Neurology|October 6, 2017
The social and economic burden of frontotemporal degenerationJames E Galvin, David H Howard, Sharon S Denny, et al.
Medical Care Research and Review : MCRR|November 13, 2025
Do Must-Access Prescription Drug Monitoring Programs (PDMPs) Affect Pain and Impairment Outcomes in Older Adults?Martha Wetzel, David H Howard, Nicholas A Giordano, et al.
Cancer|June 17, 2021
Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancerTimothy P Quinn, Martin G Sanda, David H Howard, et al.
Health Affairs (Project Hope)|March 6, 2013
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendationDavid H Howard, Florence K Tangka, Gery P Guy, et al.
The International Journal on Drug Policy|March 21, 2026
Early effects of scheduling gabapentin on medication adherence among epilepsy patients on gabapentin in VirginiaMartha Wetzel, David H Howard, Nicholas A Giordano, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Do Must-Access Prescription Drug Monitoring Programs (PDMPs) Affect Pain and Physical Impairment Outcomes in Older Adults?Martha Wetzel, David H Howard, Nicholas A Giordano, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 10, 2022
Shared Decision-Making for Implantable Cardioverter-Defibrillators: Policy Goals, Metrics, and ChallengesBirju R Rao, Faisal M Merchant, David H Howard, et al.
Medical Care|May 29, 2004
Patient satisfaction with primary care: does type of practitioner matter?Douglas W Roblin, Edmund R Becker, E Kathleen Adams, et al.
Cancer|September 16, 2015
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screeningDavid H Howard, Thomas B Richards, Peter B Bach, et al.
Clinical Therapeutics|October 26, 2006
Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohortJasmanda H Wu, David H Howard, John E McGowan, et al.
Pageof 12